Skip to main content
. 2018 Oct 15;35(5):372–387. doi: 10.1177/1455072518778493

Table 2.

Differences in demographics, personality traits and psychological problems between users and non-users of stimulant and depressant PCE drugs at T1 (N = 9370).

Users and non-users of stimulant PCE drugs Users and non-users of depressant PCE drugs
Users
(n = 193)
Non-users
(n = 9177)
Test of group differences Users
(n = 139)
Non-users
(n = 9223)
Test of group differences
Outcome variables % M SD % M SD χ2/F Eta2 % M SD % M SD χ2/F Eta2
Sex 30.39***  0.05
 Male 55.4 36.1 37.4 36.5
 Female 44.6 63.9 62.6 63.5
Age 24.9 4.9 24.9 6.5  0.05 .000 26.5 5.9 24.8 6.4  9.31** .001
 17–25 years 66.3 74.2 51.1 73.9
 26–30 years 22.8 15.1 31.7 14.9
 31–40 years 8.8 6.7 14.4 6.5
 > 40 years 2.1 4.1 2.9 4.0
Single  0.20  0.07
 Yes 48.7 47.1 48.2 47.1
 No 51.3 52.9 51.8 52.9
Born in Norway  17.67***  12.94***
 Yes 85.0 92.9 84.9 92.9
 No 15.0 7.1 15.1 7.1
Extroversion 14.5 3.8 14.1 3.6  2.51 .000 12.9 3.8 14.1 3.6  13.29*** .001
Agreeableness 16.4 2.9 16.9 2.8  4.46* .000 16.7 2.8 16.9 2.8  0.19 .000
Conscientiousness 13.2 3.6 14.7 3.2 38.32*** .004 13.2 3.8 14.7 3.2  29.62*** .003
Neuroticism 11.6 4.2 11.0 3.7  4.44* .000 13.5 3.9 11.0 3.7  64.86*** .007
Intellect/openness 16.2 3.3 14.6 3.2 49.50*** .005 16.1 3.1 14.6 3.2  28.83*** .003
Depression 27.3 8.7 24.1 7.3 35.33*** .004 30.9 9.6 24.1 7.3 118.17*** .012
Anxiety 16.8 5.0 15.0 4.0 39.13*** .004 19.7 5.9 15.0 4.0 189.71*** .020
Alcohol use 10.5 6.0 8.1 4.8 43.15*** .005 9.5 5.4 8.1 4.8  10.23** .001

Note. PCE = pharmacological cognitive enhancement.

* p < .05. ** p < .01. *** p < .001.